Innovative Financial Toxicity Tumor Board Reduces Cancer Treatment Expenses

A groundbreaking initiative at the Atrium Health Levine Cancer Institute has demonstrated significant success in alleviating the financial burden faced by cancer patients. Since its inception in 2019, the Financial Toxicity Tumor Board has served as a dedicated multidisciplinary team focused exclusively on tackling the financial distress associated with cancer care. Unlike traditional tumor boards, which concentrate solely on medical treatment, this specialized forum includes members from clinical, supportive, and administrative sectors collaborating to identify and implement financial solutions for patients.

A recent five-year analysis published in the Journal of the National Comprehensive Cancer Network highlights the impactful outcomes of this program. The study reveals that over 70 patient cases were discussed in the board meetings, resulting in immediate individual solutions and systemic changes aimed at reducing costs. The program has assisted 9,321 patients with copay assistance, saving them over $10 million, alongside providing nearly $393 million worth of free medications to more than 16,495 patients.

The board's processes include referrals from patients, family members, caregivers, and healthcare providers. It also encompasses a Patient Assistance Program designed to review treatment plans and determine eligibility for free drugs or financial aid, with pharmacy technicians playing a key role. Additionally, the program helps patients secure grants from various foundations, assist with insurance claim appeals, and address denials to ensure coverage without causing financial hardship.

A notable example involves a patient losing employer-based insurance due to an inability to work. The board intervenes by obtaining transportation, food, and expense grants, beyond facilitating COBRA insurance options. Such interventions not only improve individual patient outcomes but also foster a proactive approach to prevent financial crises among similar patients.

Expert insights from Dr. Thomas G. Knight emphasize that this comprehensive model showcases how systemic, targeted efforts can lead to substantial cost savings and enhanced quality of life for cancer patients. Consequently, the success of this initiative advocates for other cancer centers to adopt similar strategies, potentially establishing a new standard of care to support patients' financial well-being.

This innovative approach underscores the importance of integrating financial support services within oncology care to improve overall treatment effectiveness and patient outcomes. The findings from this study serve as a compelling model for reducing financial toxicity nationwide.

Source: https://medicalxpress.com/news/2025-04-highlights-success-financial-toxicity-tumor.html